Srikanta Kanungo to Seroepidemiologic Studies
This is a "connection" page, showing publications Srikanta Kanungo has written about Seroepidemiologic Studies.
Connection Strength
0.072
-
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021. Int J Infect Dis. 2021 Jul; 108:145-155.
Score: 0.018
-
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India. Sci Rep. 2021 05 18; 11(1):10551.
Score: 0.018
-
Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys. Epidemiol Infect. 2021 04 27; 149:e139.
Score: 0.018
-
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey. Lancet Glob Health. 2021 03; 9(3):e257-e266.
Score: 0.018